Drugwatch.com is updated constantly with the latest news on medical research, clinical trials, recalls and FDA warnings.
We offer free informational pamphlets on Actos, transvaginal mesh and hip replacements. Request yours today.
Our Patient Advocates answer the phone seven days a week, to make sure you get the medical answers you need.
"I am very pleased with the fast service that Drugwatch gave me for my problem. Everyone was very pleasant and got the paperwork going fast. I recommend them for any legal help you may need." - Anne Marie, hip patient
"I was impressed with the quick action your organization exhibited when I called seeking referrals for legal counsel in pending action against a provider of metal-on-metal hip replacement devices. I selected your recommendation for counsel." - Glen Lyle, hip patient
This type 2 diabetes drug is tied to the development of bladder cancer.
Metal-on-metal hips often have serious complications.
Severe back and leg pain and implant failure are among the complications with this product.
These implants treat pelvic organ prolapse but can cause life-changing complications.
Did your child suffer birth defects after you took an SSRI during pregnancy?
The Mirena IUD can migrate and cause uterine perforations, infections and severe pain.
This blood thinning drug can cause uncontrolled bleeding.
This faulty knee implant can create multiple problems for some recipients.
Have you been affected by one of these drugs or devices? Call us today for assistance.
Magnetic resonance imaging (MRI) may help doctors detect tissue damage in patients with metal-on-metal (MoM) hip implants before pain sets in, according to a new study. The study, published in the May 2013 issue of The Journal of Bone and [...]
A panel of U.S. Food and Drug Administration (FDA) advisers voted to give the public more access to Avandia, a former blockbuster diabetes drug whose sales plummeted amid safety concerns and whose access was once restricted by the FDA [...]
In 2012, Johnson & Johnson agreed to pay up to $2.2 billion to settle a federal investigation into its sales practices. But, according to The Wall Street Journal, the drug giant is now threatening to back out of the deal [...]